What is the Price of the Potential for a Meaningful Recovery following Intracerebral Hemorrhage?

In this issue of the Journal of Stroke and Cerebrovascular Diseases, Vardanyan and colleagues report on the cost-utility of minimally invasive surgery (MIS) with thrombolysis for spontaneous intracerebral hemorrhage (ICH) from the perspective of the United Kingdom (UK) National Health Service (NHS)1 using data from the Minimally Invasive Surgery Plus Alteplase in Intracerebral Hemorrhage Evacuation (MISTIE III) trial2 and the UK Sentinel Stroke National Audit Programme (SSNAP).3 The economic evaluation revealed that the incremental cost-effectiveness ratio for MIS with thrombolysis fell significantly above the UK's National Institute for Health and Clinical Excellence (NICE) threshold of £20,000 to £30,000 per quality-adjusted life year (QALY).
Source: Journal of Stroke and Cerebrovascular Diseases - Category: Neurology Authors: Source Type: research